DZHK-Retreat
Kontakt:
Dr. Ute Eggers
Referentin Wissenschaftlicher Austausch | Gruppe Strategie, Präklinische Forschung & Nachwuchsförderung
E-mail: retreat(at)dzhk.de
Retreat 2020 is going digital
Aufgrund der Corona-Krise wird das DZHK-Retreat 2020 nicht als Präsenz-, sondern als Online-Veranstaltung stattfinden.
Es wird unser erstes digitales Retreat sein. Das Programm findet statt am Donnerstag, 17. September, von 15.30 Uhr bis 18.30 Uhr und am Freitag, 18. September, von 13.00 Uhr bis 17.15 Uhr.
Retreat Programme
| Day 1 | Thursday, 17 September 2020 – 03:30 pm to 06:30 pm |
| 03:30 pm – 04:05 pm | Opening: Welcome & DZHK State of Affairs, Thomas Eschenhagen, Hamburg/Kiel/Lübeck |
| 04:15 pm – 04:20 pm | Break |
| 04:20 pm – 06:30 pm | 1 st Session: New concepts in inflammatory cardiovascular disease, Chairs: Michael Joner, Friederike Schreiter |
| 04:25 pm – 04:35 pm | Innervation regulates arterial inflammation, Sarajo Mohanta, Munich |
| 04:40 pm – 04:55 pm | Clonal hematopoiesis regulates vascular inflammation, Andreas Zeiher, Rhine-Main |
| 05:00 pm – 05:15 pm | GITR a novel checkpoint in atherosclerosis, Esther Lutgens, Munich/Amsterdam |
| 05:20 pm – 05:35 pm | scRNA-seq analysis of murine atherosclerosis, Alma Zernecke-Madsen (Würzburg) |
| 05:40 pm – 05:55 pm | Platelets and cardiovascular inflammation, Steffen Massberg, Munich |
| 06:00 pm – 06:15 pm | An unexpected role for basophils in healing after myocardial infarction, Florian Leuschner, Heidelberg/Mannheim |
| 06:20 pm – 06:30 pm | Brief wrap-up |
| Day 2 | Friday, 18 September 2020 – 01:00 pm to 05:15 pm |
| 01:00 pm – 01:20 pm | Keynote, Chair: Lars Mägdefessel, Immuno-imaging and immunotherapy in atherosclerosis, Zahi Fayad (Icahn School of Medicine at Mount Sinai, New York) |
| 01:30 pm – 02:35 pm | 2nd Session: Flash Talks Paper of the Month, Chairs: Shirin Doroudgar, Eileen Moritz |
| 01:35 pm – 01:38 pm | Midkine drives cardiac inflammation by promoting neutrophil trafficking and NETosis in myocarditis, Ulrich Grabmaier, Munich |
| 01:40 pm – 01:43 pm | ApoE attenuates unresolvable inflammation by complex formation with activated C1q, Changjun Yin, Munich |
| 01:45 pm – 01:48 pm | High-throughput single-cell rheology in complex samples by dynamic real-time deformability cytometry, Bob Fregin, Greifswald |
| 01:50 pm – 01:53 pm | Cardiovascular disease burden from ambient air pollution in Europe reassessed using novel hazard ratio functions, Andreas Daiber, Rhein-Main |
| 01:55 pm – 01:58 pm | Externalized histone H4 orchestrates chronic inflammation by inducing lytic cell death, Carlos Silvestre-Roig, Munich |
| 02:00 pm – 02:03 pm | The translational landscape of the human heart, Jana Felicitas Schulz, Berlin |
| 02:05 pm – 02:08 pm | Magnetic resonance perfusion or fractional flow reserve in coronary disease, Eike Nagel, Rhine-Main |
| 02:10 pm – 02:13 pm | Application of highsSensitivity troponin in suspected myocardial infarction, Johannes T. Neumann, Hamburg/Kiel/Lübeck |
| 02:15 pm – 02:18 pm | TIP30 counteracts cardiac hypertrophy and failure by inhibiting translational elongation, Jörg Heineke, Heidelberg/Mannheim |
| 02:20 pm – 02:23 pm | Cardiac alpha-Actin (ACTC1) gene mutation causes atrial-septal defects associated with late-onset dilated cardiomyopathy, Derk Frank, Hamburg/Kiel/Lübeck |
| 02:25 pm – 02:28 pm | Ticagrelor or prasugrel in patients with acute coronary syndromes, Stefanie Schüpke, Munich |
| 02:30 pm – 02:33 pm | Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the Multinational Cardiovascular Risk Consortium, Fabian Brunner (Hamburg) |
| 02:35 pm – 02:50 pm | Break |
| 02:50 pm – 05:00 pm | 3rd Session: Targeting the inflammasome in clinical practice, Chairs: Tommaso Gori, Lucia Natarelli |
| 02:55 pm – 03:15 pm | Targeting the NLRP3 inflammasome in inflammatory diseases, Eike Latz (Bonn) |
| 03:25 pm – 03:35 pm | Do we need sex specific therapeutic adaptation? Elke Dworatzek, Berlin |
| 03:40 pm – 03:50 pm | Phenotyping myocarditis to guide therapy, Valentina Puntmann, Rhine-Main |
| 03:55 pm – 04:05 pm | Pleiotropic effects and inflammation: Targeting the comorbidities, Stephan von Haehling, Göttingen |
| 04:10 pm – 04:20 pm | Rhythm control therapy in patients with atrial fibrillation: a translational update, Paulus Kirchhof, Hamburg/Kiel/Lübeck |
| 04:25 pm – 04:35 pm | Addressing inflammation by lipid reduction – novel molecular therapies, Ulf Landmesser, Berlin |
| 04:40 pm – 04:45 pm | Wrap-up and introduction of the new DZHK Workshop series |
| 04:45 pm – 05:15 pm | Some words of gratitude to Thomas Eschenhagen und Joachim Krebser |
Allgemein
Das DZHK-Retreat ist die wissenschaftliche Jahrestagung des DZHK, welche einmal jährlich an wechselnden Standorten stattfindet. Für das Retreat kommen rund 250 DZHK-Wissenschaftlerinnen und Wissenschaftler aus den Standorten und Partnereinrichtungen zusammen, um neueste Entwicklungen der Herz-Kreislaufmedizin zu diskutieren. Neben themenspezifischen Sessions, geben renommierte Keynote Speaker aus aller Welt wichtige Impulse für die Forschung. Flankierend finden Arbeitsgruppen- und Gremiensitzungen sowie eine Posterausstellung statt. Im Vorfeld der Veranstaltung trifft sich das Young-DZHK zum Young-DZHK Retreat.